Citizens JMP Slashes PT on OrthoPediatrics (KIDS) to $35 From $50, Keeps an Outperform Rating

OrthoPediatrics Corp. (NASDAQ:KIDS) is one of the best medical device stocks to buy according to analysts. On August 8, Citizens JMP analyst David Turkaly lowered the firm’s price target on OrthoPediatrics Corp. (NASDAQ:KIDS) to $35 from $50 while keeping an Outperform rating on the shares.

The analyst told investors in a research note that OrthoPediatrics Corp. (NASDAQ:KIDS) reported a quarterly record on its top line.

He added that while adjusted EBITDA and revenues were shy of consensus, OrthoPediatrics Corp. (NASDAQ:KIDS) is continually taking share in all its key market segments.

Management also reiterated the full-year guidance, leading the analyst to believe that the company’s fundamentals remain solid.

OrthoPediatrics Corp. (NASDAQ:KIDS) is an orthopedic company that designs, develops, and markets anatomically appropriate implants and devices for children with orthopedic conditions. The company’s offerings include products related to sports medicine, trauma, deformity, scoliosis, and other procedures.

While we acknowledge the potential of KIDS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.